74M-32894-78540 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-28
Dose 1 — Pfizer-BioNTech
2021-01-18
Dose 2 — Pfizer-BioNTech
2021-01-22
Registered in v-safe
2021-01-22
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache · Be unable to work

Adult check-in
2021-01-22
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-23
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache

Adult check-in
2021-01-25
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-02-01
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-10
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Survey response — day 35, dose 2
MedDRA: Pre-eclampsia, Pregnancy — Feeling: Fair · Be unable to work

Free text: New diagnosis preeclampsia at week 32 of pregnancy.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-23
Report sent to call center — day 35, dose 2
Be unable to work

1 call case(s)
2021-03-03
Survey response — day 42, dose 2
MedDRA: Pre-eclampsia, Pregnancy, Unevaluable event — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Severe preeclampsia now at 33 and 6 wks. · Healthcare visit (other): Preeclampsia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-03
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-13
Call 1 — Left Voicemail
2021-04-20
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-01-18
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-28	Pfizer-BioNTech
2	2021-01-18	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-22	Unsuccessful
2021-02-23	Unsuccessful
2021-03-03	Unsuccessful

Free text

Release 4 — day 35, dose 2

2021-02-23

Symptoms: New diagnosis preeclampsia at week 32 of pregnancy.

Release 5 — day 42, dose 2

2021-03-03

Symptoms: Severe preeclampsia now at 33 and 6 wks.

Healthcare visit (other): Preeclampsia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	✓	✓	✓
SD	Pre-eclampsia	✓	✓	✓
SD	Pregnancy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release